Scholar Rock Holding Corp

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

SRRK$51.55+9.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share data)(In thousands, except share data)(In thousands, except share data)(In thousands)Notes to Condensed Consolidated Financial Statements 1. Nature of the Business 2. Summary of Significant Accounting Policies 3. Fair Value of Financial Assets and Liabilities 4. Marketable Securities 5. Prepaid Expenses and Other Current Assets 6. Accrued Expenses 8. Equity-Based Compensation 9. Leases 11. Debt 12. Net Loss per Share

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (no text here)

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 3. Quantitative and Qualitative Disclosures About Market Risk (no text here)

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Item 4. Controls and Procedures (no text here)

Item 4. Controls and Procedures

PART II. OTHER INFORMATION

Item 1. Legal Proceedings (no text here)

Item 1. Legal Proceedings Item 1A. Risk Factors

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds (no text here)

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Item 3. Defaults Upon Senior Securities (no text here)

Item 3. Defaults Upon Senior Securities

Item 4. Mine Safety Disclosures (no text here)

Item 4. Mine Safety Disclosures

Item 5. Other Information (no text here)

Item 5. Other Information

Item 6. Exhibits (no text here)

Item 6. Exhibits SIGNATURES

12. Net Loss per Share

The Company calculates basic net loss per share by dividing net loss by the weighted average number of common shares outstanding. The weighted average number of common shares used in the basic and diluted net loss per share calculation includes the pre-funded warrants issued in connection with the Company’s November 2020, June 2022 and October 2024 follow-on offerings as the pre-funded warrants are exercisable at any time for nominal cash consideration. The Company has generated a net loss in all periods presented, so the basic and diluted net loss per share are the same, as the inclusion of the potentially dilutive securities would be anti-dilutive.

The following table sets forth the outstanding common stock equivalents, presented based on amounts outstanding at each period end, that have been excluded from the calculation of diluted net loss per share for the periods indicated because their inclusion would have been anti-dilutive:

	As of June 30,
	2026	2025
RSUs	3,598,746	3,548,667
PSUs	1,450,809	1,100,000
Stock options	6,686,383	9,067,448
Warrants	—	8,220,620
	11,735,938	21,936,735

Segment Reporting

The Company operates and manages its business on a consolidated basis as asingle reportable andsingle operating segment for the purposes of assessing performance and making operating decisions. The Company’s chief executive officer, who is the chief operating decision maker (“CODM”), reviews the Company’s financial information on a consolidated basis for purposes of evaluating financial performance and allocating resources. When evaluating the Company’s financial performance, the CODM regularly reviews net loss. The CODM considers net loss in making decisions on how to allocate resources. Net loss is used to monitor budget versus actual results in an effort to refine forecasts and control costs. The measure of segment assets is reported on the balance sheet as total consolidated assets.

All of the Company’s material long-lived assets are held in the United States and Switzerland. Long-lived assets are comprised of property and equipment and operating lease right-of-use assets. As of June 30, 2026, long-lived assets based in the United States and Switzerland was $8.6 million and $1.2 million, respectively. As of December 31, 2025, all of the Company’s material long-lived assets were held in the United States.

The following table presents significant expense information about the Company’s operating segment (in thousands):

Three Months Ended June 30, · Six Months Ended June 30,
2026 · 2025 · 2026 · 2025
Operating expenses:
Employee related expense(1)	$	37,445	$	32,484	$	74,971	$	55,422
External R&D expense - apitegromab		22,948		27,956		43,209		47,257
External R&D expense - SRK-181		9		792		45		1,902
External R&D expense - SRK-439		3,760		2,575		5,519		6,854
External R&D expense - Early research and other		1,610		2,227		2,820		3,682
External expense - G&A		16,597		14,952		32,729		23,895
Other segment items(2)		6,573		6,273		13,082		11,531
Equity-based compensation expense		19,662		24,433		37,907		37,846
Depreciation and amortization expense		297		417		632		810
Loss on disposal of property and equipment		-		-		3		-
Other non-operating expense/(income), net		995		(2,078)		4,489		(4,445)
Net loss	$	109,896	$	110,031	$	215,406	$	184,754

(1)

Excludes equity-based compensation expense.

(2)

Consists of other segment expenses related to supplies, corporate and facilities expenses.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.